Here, we report the case of a 50-year-old man with a 16-year history of diabetes
[,] This systematic review aimed to analyze clinical trial data regarding the efficacy and safety of GLP-1 in the management of GDM and to assess the current evidence on the safety and efficacy of GLP-1 receptor agonists as pharmacologic options for managing GDM, based on available clinical trial data
The process was painless Great service, great products, great quality
References Sikiric, P., et al
Both medications slow gastric emptying, reducing post-meal glucose spikes and promoting satiety
Therefore, tirzepatide may need to be taken for an extended period unless advised otherwise by our healthcare professionals